Hydroxyurea and EPO in Sickle Cell Disease

Clinical trial NCT05451940 · COMPLETED

Trial details

NCT number: NCT05451940
Sponsor: Julia Xu
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anemia, Sickle Cell Sickle Cell Disease

Start date: 2023-05-25
Primary completion: 2024-12-13
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.